nodes	percent_of_prediction	percent_of_DWPC	metapath
Erythromycin—SLCO1A2—Spironolactone—dilated cardiomyopathy	0.513	0.634	CbGbCtD
Erythromycin—ABCB1—Lisinopril—dilated cardiomyopathy	0.158	0.195	CbGbCtD
Erythromycin—ABCB1—Spironolactone—dilated cardiomyopathy	0.139	0.171	CbGbCtD
Erythromycin—Eruption—Furosemide—dilated cardiomyopathy	0.00618	0.0447	CcSEcCtD
Erythromycin—SLC22A7—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.0058	0.11	CbGpPWpGaD
Erythromycin—Nephritis interstitial—Furosemide—dilated cardiomyopathy	0.00563	0.0408	CcSEcCtD
Erythromycin—Tubulointerstitial nephritis—Furosemide—dilated cardiomyopathy	0.00496	0.0359	CcSEcCtD
Erythromycin—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.00457	0.0331	CcSEcCtD
Erythromycin—Hearing impaired—Furosemide—dilated cardiomyopathy	0.00399	0.0289	CcSEcCtD
Erythromycin—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00387	0.0281	CcSEcCtD
Erythromycin—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00332	0.024	CcSEcCtD
Erythromycin—Deafness—Furosemide—dilated cardiomyopathy	0.00308	0.0223	CcSEcCtD
Erythromycin—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.00285	0.0207	CcSEcCtD
Erythromycin—Irritability—Furosemide—dilated cardiomyopathy	0.00263	0.0191	CcSEcCtD
Erythromycin—Discomfort—Spironolactone—dilated cardiomyopathy	0.00257	0.0186	CcSEcCtD
Erythromycin—Confusional state—Spironolactone—dilated cardiomyopathy	0.00251	0.0182	CcSEcCtD
Erythromycin—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00249	0.0181	CcSEcCtD
Erythromycin—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.00248	0.018	CcSEcCtD
Erythromycin—MLNR—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00238	0.0453	CbGpPWpGaD
Erythromycin—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.00237	0.0172	CcSEcCtD
Erythromycin—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00234	0.0169	CcSEcCtD
Erythromycin—Injury—Lisinopril—dilated cardiomyopathy	0.00225	0.0163	CcSEcCtD
Erythromycin—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00211	0.0153	CcSEcCtD
Erythromycin—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00205	0.0149	CcSEcCtD
Erythromycin—Urticaria—Spironolactone—dilated cardiomyopathy	0.00198	0.0143	CcSEcCtD
Erythromycin—Irritability—Lisinopril—dilated cardiomyopathy	0.00198	0.0143	CcSEcCtD
Erythromycin—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.00186	0.0135	CcSEcCtD
Erythromycin—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00184	0.0133	CcSEcCtD
Erythromycin—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.0018	0.0131	CcSEcCtD
Erythromycin—Tinnitus—Furosemide—dilated cardiomyopathy	0.00178	0.0129	CcSEcCtD
Erythromycin—Pruritus—Spironolactone—dilated cardiomyopathy	0.00176	0.0128	CcSEcCtD
Erythromycin—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.00175	0.0127	CcSEcCtD
Erythromycin—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00171	0.0124	CcSEcCtD
Erythromycin—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00171	0.0123	CcSEcCtD
Erythromycin—Erythema—Furosemide—dilated cardiomyopathy	0.00166	0.012	CcSEcCtD
Erythromycin—Dizziness—Spironolactone—dilated cardiomyopathy	0.00165	0.0119	CcSEcCtD
Erythromycin—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00163	0.0118	CcSEcCtD
Erythromycin—ABCC1—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.0016	0.0305	CbGpPWpGaD
Erythromycin—Vomiting—Spironolactone—dilated cardiomyopathy	0.00158	0.0115	CcSEcCtD
Erythromycin—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.00158	0.0115	CcSEcCtD
Erythromycin—Rash—Spironolactone—dilated cardiomyopathy	0.00157	0.0114	CcSEcCtD
Erythromycin—Jaundice—Lisinopril—dilated cardiomyopathy	0.00155	0.0113	CcSEcCtD
Erythromycin—Vertigo—Furosemide—dilated cardiomyopathy	0.00149	0.0108	CcSEcCtD
Erythromycin—Nausea—Spironolactone—dilated cardiomyopathy	0.00148	0.0107	CcSEcCtD
Erythromycin—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00143	0.0104	CcSEcCtD
Erythromycin—Hallucination—Lisinopril—dilated cardiomyopathy	0.00142	0.0103	CcSEcCtD
Erythromycin—Confusional state—Furosemide—dilated cardiomyopathy	0.00137	0.0099	CcSEcCtD
Erythromycin—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00136	0.00982	CcSEcCtD
Erythromycin—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00135	0.00981	CcSEcCtD
Erythromycin—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00134	0.00967	CcSEcCtD
Erythromycin—Anorexia—Furosemide—dilated cardiomyopathy	0.00129	0.00936	CcSEcCtD
Erythromycin—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00128	0.00926	CcSEcCtD
Erythromycin—MLNR—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.00128	0.0243	CbGpPWpGaD
Erythromycin—MLNR—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.00128	0.0243	CbGpPWpGaD
Erythromycin—Erythema—Lisinopril—dilated cardiomyopathy	0.00125	0.00903	CcSEcCtD
Erythromycin—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00122	0.00884	CcSEcCtD
Erythromycin—MLNR—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.00119	0.0226	CbGpPWpGaD
Erythromycin—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00118	0.00854	CcSEcCtD
Erythromycin—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.00116	0.0221	CbGpPWpGaD
Erythromycin—Pain—Furosemide—dilated cardiomyopathy	0.00116	0.0084	CcSEcCtD
Erythromycin—Vertigo—Lisinopril—dilated cardiomyopathy	0.00112	0.00811	CcSEcCtD
Erythromycin—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00112	0.00809	CcSEcCtD
Erythromycin—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00111	0.00803	CcSEcCtD
Erythromycin—Palpitations—Lisinopril—dilated cardiomyopathy	0.0011	0.00798	CcSEcCtD
Erythromycin—Urticaria—Furosemide—dilated cardiomyopathy	0.00108	0.0078	CcSEcCtD
Erythromycin—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00107	0.00776	CcSEcCtD
Erythromycin—Chest pain—Lisinopril—dilated cardiomyopathy	0.00106	0.00769	CcSEcCtD
Erythromycin—Discomfort—Lisinopril—dilated cardiomyopathy	0.00105	0.00759	CcSEcCtD
Erythromycin—Confusional state—Lisinopril—dilated cardiomyopathy	0.00103	0.00743	CcSEcCtD
Erythromycin—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00102	0.00737	CcSEcCtD
Erythromycin—MLNR—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.001	0.019	CbGpPWpGaD
Erythromycin—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000999	0.00724	CcSEcCtD
Erythromycin—MLNR—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.000995	0.0189	CbGpPWpGaD
Erythromycin—MLNR—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.000982	0.0187	CbGpPWpGaD
Erythromycin—Anorexia—Lisinopril—dilated cardiomyopathy	0.00097	0.00702	CcSEcCtD
Erythromycin—Pruritus—Furosemide—dilated cardiomyopathy	0.000959	0.00695	CcSEcCtD
Erythromycin—MLNR—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00093	0.0177	CbGpPWpGaD
Erythromycin—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000928	0.00672	CcSEcCtD
Erythromycin—MLNR—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.0009	0.0171	CbGpPWpGaD
Erythromycin—Dizziness—Furosemide—dilated cardiomyopathy	0.000897	0.00649	CcSEcCtD
Erythromycin—MLNR—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.00089	0.0169	CbGpPWpGaD
Erythromycin—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000884	0.00641	CcSEcCtD
Erythromycin—ABCC1—S1P1 pathway—RAC1—dilated cardiomyopathy	0.00088	0.0167	CbGpPWpGaD
Erythromycin—Pain—Lisinopril—dilated cardiomyopathy	0.00087	0.0063	CcSEcCtD
Erythromycin—Vomiting—Furosemide—dilated cardiomyopathy	0.000862	0.00624	CcSEcCtD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000857	0.0163	CbGpPWpGaD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000857	0.0163	CbGpPWpGaD
Erythromycin—Rash—Furosemide—dilated cardiomyopathy	0.000855	0.00619	CcSEcCtD
Erythromycin—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000838	0.00607	CcSEcCtD
Erythromycin—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000832	0.00603	CcSEcCtD
Erythromycin—Urticaria—Lisinopril—dilated cardiomyopathy	0.000808	0.00585	CcSEcCtD
Erythromycin—Nausea—Furosemide—dilated cardiomyopathy	0.000805	0.00583	CcSEcCtD
Erythromycin—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000804	0.00582	CcSEcCtD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000797	0.0151	CbGpPWpGaD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000771	0.0147	CbGpPWpGaD
Erythromycin—MLNR—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000769	0.0146	CbGpPWpGaD
Erythromycin—ABCB1—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.000763	0.0145	CbGpPWpGaD
Erythromycin—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00075	0.00543	CcSEcCtD
Erythromycin—MLNR—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00073	0.0139	CbGpPWpGaD
Erythromycin—Pruritus—Lisinopril—dilated cardiomyopathy	0.00072	0.00521	CcSEcCtD
Erythromycin—MLNR—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.0007	0.0133	CbGpPWpGaD
Erythromycin—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000696	0.00504	CcSEcCtD
Erythromycin—MLNR—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.000691	0.0131	CbGpPWpGaD
Erythromycin—Dizziness—Lisinopril—dilated cardiomyopathy	0.000673	0.00487	CcSEcCtD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000659	0.0125	CbGpPWpGaD
Erythromycin—MLNR—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000652	0.0124	CbGpPWpGaD
Erythromycin—MLNR—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000652	0.0124	CbGpPWpGaD
Erythromycin—Vomiting—Lisinopril—dilated cardiomyopathy	0.000647	0.00468	CcSEcCtD
Erythromycin—Rash—Lisinopril—dilated cardiomyopathy	0.000642	0.00465	CcSEcCtD
Erythromycin—MLNR—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000626	0.0119	CbGpPWpGaD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000625	0.0119	CbGpPWpGaD
Erythromycin—MLNR—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000607	0.0115	CbGpPWpGaD
Erythromycin—Nausea—Lisinopril—dilated cardiomyopathy	0.000604	0.00438	CcSEcCtD
Erythromycin—MLNR—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000587	0.0112	CbGpPWpGaD
Erythromycin—SLC22A7—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000528	0.01	CbGpPWpGaD
Erythromycin—MLNR—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000502	0.00954	CbGpPWpGaD
Erythromycin—MLNR—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000476	0.00905	CbGpPWpGaD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000464	0.00881	CbGpPWpGaD
Erythromycin—ABCC1—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000442	0.0084	CbGpPWpGaD
Erythromycin—MLNR—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000435	0.00826	CbGpPWpGaD
Erythromycin—SLCO1A2—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000394	0.00749	CbGpPWpGaD
Erythromycin—CYP1A2—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000379	0.0072	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000369	0.00701	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000369	0.00701	CbGpPWpGaD
Erythromycin—MLNR—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000353	0.00671	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000343	0.00652	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000335	0.00637	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000335	0.00637	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000332	0.00631	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000311	0.00592	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000304	0.00578	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000301	0.00573	CbGpPWpGaD
Erythromycin—MLNR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000298	0.00567	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000286	0.00543	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000284	0.00539	CbGpPWpGaD
Erythromycin—SLC22A7—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000276	0.00525	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000273	0.0052	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000269	0.00511	CbGpPWpGaD
Erythromycin—SLC22A7—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000268	0.0051	CbGpPWpGaD
Erythromycin—SLC22A7—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000268	0.0051	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000257	0.0049	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000257	0.00489	CbGpPWpGaD
Erythromycin—SLC22A7—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00025	0.00474	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000244	0.00464	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000223	0.00424	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000216	0.00411	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000209	0.00397	CbGpPWpGaD
Erythromycin—SLCO1A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000206	0.00391	CbGpPWpGaD
Erythromycin—SLCO1A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.0002	0.00381	CbGpPWpGaD
Erythromycin—SLCO1A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.0002	0.00381	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.0002	0.00379	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000198	0.00376	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000198	0.00376	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.00019	0.00361	CbGpPWpGaD
Erythromycin—SLCO1A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000186	0.00354	CbGpPWpGaD
Erythromycin—ABCC1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000185	0.00352	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000184	0.0035	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	0.000182	0.00346	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000181	0.00344	CbGpPWpGaD
Erythromycin—ABCC1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00018	0.00343	CbGpPWpGaD
Erythromycin—ABCC1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00018	0.00343	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000178	0.00339	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.000175	0.00332	CbGpPWpGaD
Erythromycin—CYP1A2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000168	0.00319	CbGpPWpGaD
Erythromycin—ABCC1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000168	0.00319	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	0.000152	0.0029	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000152	0.00289	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000144	0.00274	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	0.000142	0.00269	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	0.000137	0.0026	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000135	0.00257	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—TAZ—dilated cardiomyopathy	0.000127	0.00242	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000126	0.00239	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000124	0.00236	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000122	0.00232	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—SDHA—dilated cardiomyopathy	0.000115	0.00219	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—TAZ—dilated cardiomyopathy	0.000115	0.00218	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000112	0.00213	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.000109	0.00208	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—AGT—dilated cardiomyopathy	0.000107	0.00203	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—ANKRD1—dilated cardiomyopathy	0.000106	0.00202	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000104	0.00197	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—SDHA—dilated cardiomyopathy	0.000104	0.00197	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—TAZ—dilated cardiomyopathy	9.99e-05	0.0019	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	9.77e-05	0.00186	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—SDHA—dilated cardiomyopathy	9.03e-05	0.00172	CbGpPWpGaD
Erythromycin—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	8.81e-05	0.00168	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.62e-05	0.00164	CbGpPWpGaD
Erythromycin—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	8.57e-05	0.00163	CbGpPWpGaD
Erythromycin—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	8.57e-05	0.00163	CbGpPWpGaD
Erythromycin—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	7.97e-05	0.00152	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—ANKRD1—dilated cardiomyopathy	7.86e-05	0.00149	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—ANKRD1—dilated cardiomyopathy	7.68e-05	0.00146	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	7.49e-05	0.00142	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	7.49e-05	0.00142	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—RAF1—dilated cardiomyopathy	7.43e-05	0.00141	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—TAZ—dilated cardiomyopathy	7.39e-05	0.0014	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—TAZ—dilated cardiomyopathy	7.22e-05	0.00137	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	7.13e-05	0.00136	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	7.13e-05	0.00136	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	7.02e-05	0.00133	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	6.99e-05	0.00133	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	6.84e-05	0.0013	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	6.74e-05	0.00128	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—SDHA—dilated cardiomyopathy	6.68e-05	0.00127	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	6.6e-05	0.00126	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—SDHA—dilated cardiomyopathy	6.53e-05	0.00124	CbGpPWpGaD
Erythromycin—ABCC1—Disease—NPPA—dilated cardiomyopathy	6.33e-05	0.0012	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	6.32e-05	0.0012	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	6.16e-05	0.00117	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	6.15e-05	0.00117	CbGpPWpGaD
Erythromycin—ABCC1—Disease—PSEN2—dilated cardiomyopathy	6.13e-05	0.00117	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	5.8e-05	0.0011	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	5.79e-05	0.0011	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	5.54e-05	0.00105	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	5.45e-05	0.00104	CbGpPWpGaD
Erythromycin—SLC22A7—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.44e-05	0.00103	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—EGFR—dilated cardiomyopathy	5.09e-05	0.000968	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	4.93e-05	0.000937	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	4.63e-05	0.000879	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	4.38e-05	0.000833	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	4.35e-05	0.000827	CbGpPWpGaD
Erythromycin—SLCO1A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.06e-05	0.000772	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	3.93e-05	0.000748	CbGpPWpGaD
Erythromycin—ABCC1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.66e-05	0.000695	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	3.57e-05	0.000679	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	3.36e-05	0.000638	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—GPX1—dilated cardiomyopathy	3.13e-05	0.000594	CbGpPWpGaD
Erythromycin—ABCC1—Disease—RAC1—dilated cardiomyopathy	3.08e-05	0.000586	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—CD36—dilated cardiomyopathy	3.04e-05	0.000579	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	3.04e-05	0.000577	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	3e-05	0.000571	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	2.86e-05	0.000544	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—GPX1—dilated cardiomyopathy	2.81e-05	0.000535	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—AGT—dilated cardiomyopathy	2.74e-05	0.000521	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—CD36—dilated cardiomyopathy	2.74e-05	0.000521	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—AGT—dilated cardiomyopathy	2.47e-05	0.000469	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—GPX1—dilated cardiomyopathy	2.45e-05	0.000466	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.4e-05	0.000456	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—CD36—dilated cardiomyopathy	2.39e-05	0.000454	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.34e-05	0.000444	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—AGT—dilated cardiomyopathy	2.15e-05	0.000409	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.1e-05	0.0004	CbGpPWpGaD
Erythromycin—ABCC1—Disease—RAF1—dilated cardiomyopathy	2.04e-05	0.000389	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—GPX1—dilated cardiomyopathy	1.81e-05	0.000345	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—GPX1—dilated cardiomyopathy	1.77e-05	0.000337	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—CD36—dilated cardiomyopathy	1.77e-05	0.000336	CbGpPWpGaD
Erythromycin—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.74e-05	0.000331	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—CD36—dilated cardiomyopathy	1.73e-05	0.000328	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—AGT—dilated cardiomyopathy	1.59e-05	0.000303	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—AGT—dilated cardiomyopathy	1.56e-05	0.000296	CbGpPWpGaD
Erythromycin—ABCC1—Disease—EGFR—dilated cardiomyopathy	1.4e-05	0.000267	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	1.34e-05	0.000254	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—CD36—dilated cardiomyopathy	1.3e-05	0.000248	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—AGT—dilated cardiomyopathy	1.17e-05	0.000223	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	1.07e-05	0.000203	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	1.04e-05	0.000198	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	9.37e-06	0.000178	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	8.25e-06	0.000157	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	8.03e-06	0.000153	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	7.23e-06	0.000137	CbGpPWpGaD
